We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+3.96%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$477M
AUM Growth
+$5.92M
(+1.3%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
3.36%
Top 10 Holdings %
Top 10 Hldgs %
4.53%
Holding
1,805
New
734
Increased
232
Reduced
251
Closed
586
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$1.93M |
| 2 |
Paychex
PAYX
|
+$1.88M |
| 3 |
Burlington
BURL
|
+$1.87M |
| 4 |
Constellation Brands
STZ
|
+$1.83M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.28M |
| 2 |
AT&T
T
|
+$2.32M |
| 3 |
Walt Disney
DIS
|
+$2.27M |
| 4 |
Apple
AAPL
|
+$2.21M |
| 5 |
Honeywell
HON
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.32% |
| 2 | Healthcare | 16.05% |
| 3 | Consumer Discretionary | 12.91% |
| 4 | Industrials | 12.34% |
| 5 | Financials | 12.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
BioCryst Pharmaceuticals
BCRX
$2.43B
| $332K | 0.07% |
+39,779
| New | +$383K |
|
577
M&T Bank
MTB
$36B
| $331K | 0.07% |
+2,771
| New | +$402K |
|
578
Payoneer
PAYO
$2.41B
| $331K | 0.07% |
52,685
+32,641
| +163% | +$194K |
|
579
Oramed Pharmaceuticals
ORMP
$170M
| $331K | 0.07% |
151,620
+94,537
| +166% | +$300K |
|
|
VMEO
580
DELISTED
Vimeo
VMEO
| $330K | 0.07% |
86,149
-94,030
| -52% | -$369K |
|
581
Fossil Group
FOSL
$249M
| $330K | 0.07% |
103,005
-4,677
| -4% | -$21K |
|
|
RVNC
582
DELISTED
Revance Therapeutics, Inc.
RVNC
| $329K | 0.07% |
10,215
-24
| -0.2% | -$748 |
|
583
Wingstop
WING
$3.74B
| $328K | 0.07% |
1,788
+314
| +21% | +$51.6K |
|
584
Louisiana-Pacific
LPX
$5.19B
| $327K | 0.07% |
+6,036
| New | +$369K |
|
585
Frontdoor
FTDR
$5.1B
| $327K | 0.07% |
+11,723
| New | +$310K |
|
586
Artisan Partners
APAM
$2.86B
| $327K | 0.07% |
+10,216
| New | +$343K |
|
587
Palantir
PLTR
$315B
| $327K | 0.07% |
38,658
-85,771
| -69% | -$671K |
|
|
LKFT
588
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $325K | 0.07% |
+8,416
| New | +$346K |
|
|
ALTR
589
DELISTED
Altair Engineering Inc
ALTR
| $325K | 0.07% |
+4,509
| New | +$266K |
|
|
SUM
590
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $325K | 0.07% |
+11,395
| New | +$344K |
|
591
E.W. Scripps
SSP
$271M
| $324K | 0.07% |
+34,416
| New | +$433K |
|
592
GlobalFoundries
GFS
$29.2B
| $324K | 0.07% |
+4,483
| New | +$283K |
|
593
Paycom
PAYC
$7.05B
| $322K | 0.07% |
1,058
+92
| +10% | +$27.7K |
|
594
Recursion Pharmaceuticals
RXRX
$1.6B
| $321K | 0.07% |
48,138
+30,124
| +167% | +$239K |
|
|
TGNA
595
DELISTED
TEGNA Inc
TGNA
| $321K | 0.07% |
18,957
+4,838
| +34% | +$90.5K |
|
|
MRC
596
DELISTED
MRC Global
MRC
| $320K | 0.07% |
+32,963
| New | +$374K |
|
597
Red Rock Resorts
RRR
$3.8B
| $320K | 0.07% |
+7,183
| New | +$318K |
|
598
MongoDB
MDB
$24.9B
| $320K | 0.07% |
1,373
-2,369
| -63% | -$497K |
|
599
Dycom Industries
DY
$12.7B
| $320K | 0.07% |
+3,414
| New | +$317K |
|
600
Cullen/Frost Bankers
CFR
$10.3B
| $320K | 0.07% |
+3,035
| New | +$378K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q1 2023 Portfolio in Review
As of Q1 2023, XTX Topco held 1,805 positions worth $477M, up 1.3% from $471M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.
XTX Topco deployed $16M of net new capital in Q1 2023, opening 734 new positions and adding to 232 existing holdings. Its largest new stake was Estee Lauder: 7,582 shares worth $1.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $3.28M trimmed.
- XTX Topco's largest Q1 2023 buy was Estee Lauder: 7,582 shares worth $1.87M.
- XTX Topco added most to Regeneron Pharmaceuticals in Q1 2023, an estimated $1.79M increase.
- XTX Topco's biggest Q1 2023 reduction was Alphabet (Google) Class A, cutting an estimated $3.28M.
- XTX Topco fully exited Apple in Q1 2023, selling an estimated $2.21M.
- XTX Topco's ten largest holdings make up 4.5% of its $477M portfolio in Q1 2023.
- XTX Topco opened 734 new positions and closed 586 in Q1 2023.
- XTX Topco's portfolio value rose 1.3% quarter-over-quarter to $477M.
Based on XTX Topco's 13F filing for Q1 2023, filed 12 May 2023.